Purpose In patients undergoing lumbar fusion, osteoporosis has been shown to lead to
poorer outcomes and greater incidence of fusion-related complications. Given the …

Objective As the ageing population continues to grow, the incidence of osteoporosis
continues to rise. Patients with osteoporosis are often managed pharmacologically. It is …

Purpose Osteoporosis is one of the most common conditions among adults worldwide. It
also presents a challenge among patients undergoing spinal surgery. Use of Teriparatide …

OBJECTIVE Bisphosphonates and teriparatide are the most common therapies used in the
treatment of osteoporosis. Their impact on fusion rates in osteoporotic patients following …

Purpose: To evaluate the current evidence in the literature on treatment strategies for
degenerative lumbar spine fusion in patients with osteoporosis. Methods: A systematic …

Purpose We conducted a meta-analysis of controlled clinical trials to evaluate the efficacy of
bisphosphonates in lumbar fusion. Introduction Bisphosphonates reduce bone resorption …

BACKGROUND Administering anti-osteoporotic agents to patients perioperatively is a
widely accepted approach for improving bone fusion rates and reducing the risk of …

Abstract Treatment of osteoporosis with medications like teriparatide, a parathyroid
hormone, is known to improve bone density and reduce the risk of osteoporotic vertebral …

Background Giving patients anti-osteoporotic agents peri-operatively is a well-accepted
strategy to increase fusion rate and prevent complications. The purpose of this study was to …

Management of spine surgery patients with osteoporosis is challenging because of the
difficulty of instrumenting and the potential complications, including nonunion and adjacent …